| Literature DB >> 33832058 |
Lifeng Wang1, Yongkang Guo2, Jun Tian3.
Abstract
INTRODUCTION: The comparison of ketamine with tramadol for pain control remains controversial in pediatric adenotonsillectomy or tonsillectomy. We conduct a systematic review and meta-analysis to explore the efficacy of ketamine vs tramadol for pain relief in children following adenotonsillectomy or tonsillectomy.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33832058 PMCID: PMC8036051 DOI: 10.1097/MD.0000000000022541
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Flow diagram of study searching and selection process.
Characteristics of included studies.
| Ketamine group | Tramadol group | ||||||||||||
| NO. | Author | Number | Age (years) | Female (n) | Weight (kg) | Duration of operation (min) | Methods | Number | Age (years) | Female (n) | Weight (kg) | Duration of operation (min) | Methods |
| 1 | Yenigun 2015 | 30 | 7.67 (2.59) | – | 26.62 (6.71) | 31.67 (5.15) | Intravenous (IV) ketamine (0.5 mg/kg) for tonsillectomy | 30 | 6.25 (1.96) | – | 21.17 (4.37) | 28.42 (7.13) | Tramadol hydrochloride infiltration (2 mg/kg) |
| 2 | Ugur 2013 | 25 | 5.4 (1.7) | 16 | 20.9 (7.5) | 46.0 (14.7) | Injections in peritonsillar fossa of ketamine (0.5 mg/kg to 2 mL) for adenotonsillectomy | 25 | 5.2 (1.6) | 6 | 21.2 (5.4) | 44.7 (10.2) | Injections in peritonsillar fossa of tramadol (2 mg/kg to 2 mL) |
| 3 | Tekelioglu 2013 | 20 | 5.6 (1.3) | 10 | 24.05 (5.56) | 36.5 (5.9) | Tonsillar fossae injection with 0.4 mL (20 mg) ketamine for tonsillectomy | 20 | 6.0 (1.4) | 11 | 24.95 (5.81) | 34.7 (9.2) | Tonsillar fossae injection with 0.8 mL tramadol |
| 4 | Honarmand 2013 | 30 | 7.33 (3.2) | 13 | 24.7 (10.3) | 55.5 (4.4) | IV ketamine 0.5 mg/kg for tonsillectomy | 30 | 8.3 (2.8) | 12 | 23.5 (9.9) | 55.6 (4) | Peritonsillar infiltration of tramadol 2 mg/kg |
| 5 | Ayatollahi 2012 | 42 | 8.05 (2.67) | 18 | – | 42.14 (10.43) | Peritonsillar infiltration with 0.5 mg/kg ketamine for tonsillectomy | 42 | 7.06 (2.21) | 14 | – | 40.56 (9.35) | Peritonsillar infiltration with 2 mg/kg tramadol |
| 6 | Umuroğlu 2004 | 15 | 6.9 (2.1) | 5 | 24.33 (6.54) | 43 (13.33) | IV 0.5 mg/kg ketamine for adenotonsillectomy | 15 | 6.06 (2.51) | 7 | 23.3 (10.23) | 45.6 (12.08) | IV 1.5 mg/kg tramadol |
Figure 2Risk of bias assessment. (A) Authors’ judgments about each risk of bias item for each included study. (B) Authors’ judgments about each risk of bias item presented as percentages across all included studies.
Summary of findings table.
| Comparison of ketamine with tramadol | ||||||
| Patient or population: patients with children undergoing adenotonsillectomy or tonsillectomy Settings: Intervention: ketamine Comparison: tramadol | ||||||
| Illustrative comparative risks∗ (95% CI) | ||||||
| Outcomes | Assumed risk | Corresponding risk | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments |
| Tramadol | Ketamine | |||||
| CHEOPS at 1 h | The mean cheops at 1 h in the intervention groups was | 204 (3 studies) | ⊕⊕⊝⊝ low†,‡ | |||
| CHEOPS at 6 h | The mean cheops at 6 h in the intervention groups was | 204 (3 studies) | ⊕⊕⊝⊝ low†,‡ | |||
| Sedation scale at 1 h | The mean sedation scale at 1 h in the intervention groups was | 110 (2 studies) | ⊕⊕⊝⊝ low†,‡ | |||
| Additional pain medication | 267 per 1000 | 349 per 1000 (227–539) | RR1.31 (0.85–2.02) | 120 (3 studies) | ⊕⊕⊕⊝ moderate† | |
| First time of additional pain medication | The mean first time of additional pain medication in the intervention groups was | 224 (4 studies) | ⊕⊕⊝⊝ low†,‡ | |||
CI = confidence interval, RR = risk ratio.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is very unlikely to change our confidence in the estimate of effect.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes.
The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% C).
Unclear risk of bias.
I2 > 50.
Figure 3Forest plot for the meta-analysis of CHEOPS at 1 h.
Figure 4Forest plot for the meta-analysis of CHEOPS at 6 h.
Figure 5Forest plot for the meta-analysis of sedation scale at 1 h.
Figure 6Forest plot for the meta-analysis of additional pain medication.
Figure 7Forest plot for the meta-analysis of first time of additional pain medication.